T1	Participants 409 462	Female patients between 16 and 45 years were eligible
T2	Participants 640 649	One group
T3	Participants 691 702	other group
T4	Participants 883 891	patients
T5	Participants 977 985	patients
T6	Participants 1533 1541	patients
